Board to consider Dividend

| Updated on May 19, 2016 Published on May 19, 2016

Jenburkt Pharmaceuticals Ltd has informed BSE that a Meeting of Board of Directors of the Company is scheduled to be held on May 30, 2016, inter alia, to consider:

1. To take on record the audited results for the quarter / financial year ended on March 31, 2016.

2. To recommend Dividend, if any.

Source : BSE - >www.bseindia.com

Published on May 19, 2016
This article is closed for comments.
Please Email the Editor